Skip to main content
Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · IEX Real-Time Price · USD
9.20
+0.08 (0.88%)
At close: May 17, 2024, 4:00 PM
9.12
-0.08 (-0.87%)
After-hours: May 17, 2024, 7:57 PM EDT

Arcutis Biotherapeutics Revenue

Arcutis Biotherapeutics had revenue of $106.39M in the twelve months ending March 31, 2024, with 1,545.18% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $49.57M with 1,682.42% year-over-year growth. In the year 2023, Arcutis Biotherapeutics had annual revenue of $59.61M with 1,517.09% growth.

Revenue (ttm)
$106.39M
Revenue Growth
+1,545.18%
P/S Ratio
10.08
Revenue / Employee
$359,439
Employees
296
Market Cap
1.07B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202359.61M55.92M1,517.09%
Dec 31, 20223.69M--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Collegium Pharmaceutical 566.92M
AtriCure 414.60M
Ironwood Pharmaceuticals 413.55M
Cronos Group 93.03M
AbCellera Biologics 35.79M
Silence Therapeutics 33.86M
Revenue Rankings

ARQT News

More News